Talia M. Nir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Talia M. Nir has a total of 378 co-authors. Here are the top co-authors by number of shared publications:
Neda Jahanshad
Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, CA, USA
12 shared publications- Neda Jahanshad
Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, United States
12 shared publications Paul M. Thompson
Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, CA, USA
9 shared publications- Paul Thompson
Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, California, USA
9 shared publications - Sophia I. Thomopoulos
University of Southern California
5 shared publications - Alyssa H. Zhu
Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
4 shared publications
Latest Publications
- Open Access
Regional choroid plexus calcifications and their associations with aging, brain structure, and disease
The choroid plexus (CP) maintains brain homeostasis through cerebrospinal fluid production and formation of the blood-cerebrospinal fluid barrier, and its dysfunction has been linked with aging and neurological disease. CP dysfunction may involve both enlargement and calcific tissue change, which may reflect distinct processes; yet population neuroimaging has focused on lateral ventricle CP volume, which cannot directly identify calcified tissue. Using quantitative susceptibility mapping (QSM) in 30,012 UK Biobank participants, we conducted, to our knowledge, the first large scale multi-ventricular study of CP calcification (CPcal), quantifying the lateral (LV), third (3rdV) and fourth (4thV) ventricles. We examined associations with age and sex, endocrine, nutritional and metabolic, mental and behavioral, nervous system, and circulatory diagnoses; family history of Alzheimer’s disease and related dementias (ADRD); cardiometabolic traits; and brain macrostructure, white matter microstructure, and subcortical susceptibility. CPcal increased with age (largest association: LV, r = 0.191) and was greater in males in the LV and 3rdV (d = 0.249-0.359) and more prevalent in the 4thV (OR = 1.274). Greater CPcal was associated with endocrine and metabolic, psychiatric, nervous system, and circulatory disorders, with the strongest and most consistent associations observed in the 3rdV (d = 0.097 - 0.125) and persisted after adjustment for ventricular volume, particularly for diabetes (d = 0.303) and tobacco use disorder (d = 0.314). Maternal ADRD family history was associated with greater LV CPcal (d = 0.063). CPcal was also associated with cortical and subcortical volumes (r = 0.033 - 0.046), white matter microstructure (r = 0.017 - 0.042), and subcortical susceptibility (r = −0.064 - 0.131). QSM-derived CPcal is a scalable, radiation-free imaging phenotype that complements volumetry by characterizing calcific CP tissue, which is associated with cardiometabolic health, brain aging, and neurodegenerative risk, particularly in the third ventricle.
Open AccessRegional choroid plexus calcifications and their associations with aging, brain structure, and disease
The choroid plexus (CP) maintains brain homeostasis through cerebrospinal fluid production and formation of the blood-cerebrospinal fluid barrier, and its dysfunction has been linked with aging and neurological disease. CP dysfunction may involve both enlargement and calcific tissue change, which may reflect distinct processes; yet population neuroimaging has focused on lateral ventricle CP volume, which cannot directly identify calcified tissue. Using quantitative susceptibility mapping (QSM) in 30,012 UK Biobank participants, we conducted, to our knowledge, the first large scale multi-ventricular study of CP calcification (CPcal), quantifying the lateral (LV), third (3rdV) and fourth (4thV) ventricles. We examined associations with age and sex, endocrine, nutritional and metabolic, mental and behavioral, nervous system, and circulatory diagnoses; family history of Alzheimer’s disease and related dementias (ADRD); cardiometabolic traits; and brain macrostructure, white matter microstructure, and subcortical susceptibility. CPcal increased with age (largest association: LV, r = 0.191) and was greater in males in the LV and 3rdV (d = 0.249-0.359) and more prevalent in the 4thV (OR = 1.274). Greater CPcal was associated with endocrine and metabolic, psychiatric, nervous system, and circulatory disorders, with the strongest and most consistent associations observed in the 3rdV (d = 0.097 - 0.125) and persisted after adjustment for ventricular volume, particularly for diabetes (d = 0.303) and tobacco use disorder (d = 0.314). Maternal ADRD family history was associated with greater LV CPcal (d = 0.063). CPcal was also associated with cortical and subcortical volumes (r = 0.033 - 0.046), white matter microstructure (r = 0.017 - 0.042), and subcortical susceptibility (r = −0.064 - 0.131). QSM-derived CPcal is a scalable, radiation-free imaging phenotype that complements volumetry by characterizing calcific CP tissue, which is associated with cardiometabolic health, brain aging, and neurodegenerative risk, particularly in the third ventricle.
- Open Access
FastEBM: Fast, Scalable, and Uncertainty-Aware Event-Based Disease Progression Modeling
Event-based models (EBMs) are used to infer ordering of biomarker alteration patterns with respect to disease progression. However, EBM approaches rely on computationally expensive permutation-based inference, assumptions of feature independence, and likelihood optimization that can limit scalability and stability in high-dimensional settings. Here, we introduce Fast Event-Based Model (FastEBM), a scalable, uncertainty aware, Markov- chain-based framework that reformulates disease progression inference as a subject-ordering problem on a data-driven diffusion manifold. The progression uncertainty, used to derive positional variance diagrams, is quantified using first-passage-time variability derived directly from the inferred Markov process. Using synthetic experiments varying feature dimensionality, cohort size, noise level, and feature-correlation structure, we compared FastEBM with established methods, including Gaussian mixture model EBM (GMM-EBM), kernel density estimation EBM (KDE-EBM), and discriminative EBM (DEBM). FastEBM achieved the best accuracy and runtime. In low-subject/high-dimensional stress tests, FastEBM retained event-order recovery. FastEBM remained robust in simulations containing correlated and redundant features after decorrelation and feature-group handling. We applied FastEBM to real-world data to characterize biomarker progression in Alzheimer’s disease. First, we evaluated a low-dimensional multi- modal dataset from The Alzheimer’s Disease Prediction Of Longitudinal Evolution (TAD- POLE) challenge. Second, to demonstrate high-dimensional disease progression mapping, we applied FastEBM to regional cortical tau-PET data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). In both cases, FastEBM recovered progression patterns broadly consistent with the literature, also revealing lateralized progression trends. These results show that diffusion-based Markov geometry provides a scalable and robust alternative to conventional event-based modeling. FastEBM is available at: https://github.com/sjusc07/FastEBM .
Open AccessFastEBM: Fast, Scalable, and Uncertainty-Aware Event-Based Disease Progression Modeling
Event-based models (EBMs) are used to infer ordering of biomarker alteration patterns with respect to disease progression. However, EBM approaches rely on computationally expensive permutation-based inference, assumptions of feature independence, and likelihood optimization that can limit scalability and stability in high-dimensional settings. Here, we introduce Fast Event-Based Model (FastEBM), a scalable, uncertainty aware, Markov- chain-based framework that reformulates disease progression inference as a subject-ordering problem on a data-driven diffusion manifold. The progression uncertainty, used to derive positional variance diagrams, is quantified using first-passage-time variability derived directly from the inferred Markov process. Using synthetic experiments varying feature dimensionality, cohort size, noise level, and feature-correlation structure, we compared FastEBM with established methods, including Gaussian mixture model EBM (GMM-EBM), kernel density estimation EBM (KDE-EBM), and discriminative EBM (DEBM). FastEBM achieved the best accuracy and runtime. In low-subject/high-dimensional stress tests, FastEBM retained event-order recovery. FastEBM remained robust in simulations containing correlated and redundant features after decorrelation and feature-group handling. We applied FastEBM to real-world data to characterize biomarker progression in Alzheimer’s disease. First, we evaluated a low-dimensional multi- modal dataset from The Alzheimer’s Disease Prediction Of Longitudinal Evolution (TAD- POLE) challenge. Second, to demonstrate high-dimensional disease progression mapping, we applied FastEBM to regional cortical tau-PET data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). In both cases, FastEBM recovered progression patterns broadly consistent with the literature, also revealing lateralized progression trends. These results show that diffusion-based Markov geometry provides a scalable and robust alternative to conventional event-based modeling. FastEBM is available at: https://github.com/sjusc07/FastEBM .
- Open Access
- 27 April 2026
- Published by Springer Nature in Molecular Psychiatry
Alzheimer’s disease-like brain pattern biomarker: capturing risks and predicting disease onset
Preventing Alzheimer's disease (AD) requires early-warning biomarkers. We developed a Regional Vulnerability Index (RVI) that quantifies individual brain similarity to AD patients' expected brain deficit patterns. We calculated regional effect sizes to establish brain deficit patterns in amyloid-positive AD cases compared to amyloid-negative healthy controls. RVI-AD was calculated as a linear index of individual similarity to this established brain pattern in AD. We demonstrated RVI-AD elevation associated with risk factors in 335 participants (mean age: 49 ± 13 years) in the Amish Connectome Project, followed by an independent sample consisting of 26,010 participants (mean age: 64 ± 7 years) from the UK Biobank. Genetic and cardiovascular risks were evaluated using APOE-e4 genotype and Framingham Cardiovascular Risk Scores (FCVRS), respectively. Additionally, we assessed the risk of converting from MCI to dementia in N = 1932 participants (mean age: ~74) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Healthy participants with the APOE-e4 allele had significantly elevated RVI-AD indices (p = 0.03 and 2·10-5, for ACP and UKBB samples respectively). FCVRS significantly contributed to higher RVI-AD in an interaction with APOE-e4-specific manner (p = 2·10-4 and 7·10-6 for ACP and UKBB samples respectively). In ADNI cohort, RVI-AD significantly predicted conversion from MCI to dementia in the next decade, particularly in the first three years (AUC = 70-74%, OR = 2.16, 95% CI = 1.8-2.6, p < 10-16). In healthy individuals, the RVI-AD detected the insidious impact of APOE-ε4 and cardiovascular risks in otherwise normally aging cohorts. Elevated RVI-AD also predicted conversion to dementia within ten years in the older, high-risk cohort. Further development of this brain-pattern similarity-based approach may yield a noninvasive, clinically accessible biomarker to aid early detection of the subtle to more imminent effects of AD risks.
- 27 April 2026
- Published by Springer Nature in Molecular Psychiatry
Open AccessAlzheimer’s disease-like brain pattern biomarker: capturing risks and predicting disease onset
Preventing Alzheimer's disease (AD) requires early-warning biomarkers. We developed a Regional Vulnerability Index (RVI) that quantifies individual brain similarity to AD patients' expected brain deficit patterns. We calculated regional effect sizes to establish brain deficit patterns in amyloid-positive AD cases compared to amyloid-negative healthy controls. RVI-AD was calculated as a linear index of individual similarity to this established brain pattern in AD. We demonstrated RVI-AD elevation associated with risk factors in 335 participants (mean age: 49 ± 13 years) in the Amish Connectome Project, followed by an independent sample consisting of 26,010 participants (mean age: 64 ± 7 years) from the UK Biobank. Genetic and cardiovascular risks were evaluated using APOE-e4 genotype and Framingham Cardiovascular Risk Scores (FCVRS), respectively. Additionally, we assessed the risk of converting from MCI to dementia in N = 1932 participants (mean age: ~74) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Healthy participants with the APOE-e4 allele had significantly elevated RVI-AD indices (p = 0.03 and 2·10-5, for ACP and UKBB samples respectively). FCVRS significantly contributed to higher RVI-AD in an interaction with APOE-e4-specific manner (p = 2·10-4 and 7·10-6 for ACP and UKBB samples respectively). In ADNI cohort, RVI-AD significantly predicted conversion from MCI to dementia in the next decade, particularly in the first three years (AUC = 70-74%, OR = 2.16, 95% CI = 1.8-2.6, p < 10-16). In healthy individuals, the RVI-AD detected the insidious impact of APOE-ε4 and cardiovascular risks in otherwise normally aging cohorts. Elevated RVI-AD also predicted conversion to dementia within ten years in the older, high-risk cohort. Further development of this brain-pattern similarity-based approach may yield a noninvasive, clinically accessible biomarker to aid early detection of the subtle to more imminent effects of AD risks.
- Open Access
Along-Tract Microstructural Alterations Associated with Stimulant Misuse Localized using Diffusion MRI Tractometry
Diffusion brain MRI (dMRI) studies of substance use disorders have reported widespread but modest white matter (WM) microstructural alterations with limited anatomical specificity. Here, we applied segment-wise along-tract 3D tractometry to brain dMRI scans to localize fine-scale WM alterations associated with stimulant misuse using two complementary analytical frameworks: Bundle Analytics (BUAN) and Medial Tractography Analysis (MeTA). We analyzed 3D profiles of widely-used diffusion metrics across 33 major WM bundles in independent cohorts of cocaine (74 cases;58 controls) and amphetamine (22 cases;18 controls) users, testing the statistical associations with brain microstructure of pooled stimulant effects, substance-specific effects, and direct comparisons between stimulant classes. Segment-wise analyses revealed focal differences localized to specific tract segments rather than uniform differences along entire bundles. In pooled stimulant misuse, convergent findings across analysis pipelines were localized to hippocampal pathways and were consistent with altered microstructural organization. Amphetamines misuse showed a broader pattern of segment-wise differences across commissural, projection, and association pathways, involving altered axonal organization. No robust segment-wise differences were detected for cocaine misuse or between stimulant classes. These results show that WM alterations are spatially localized and reproducible across tractometry frameworks, highlighting the value of along-tract 3D mapping for improving anatomical specificity in addiction neuroimaging.
Open AccessAlong-Tract Microstructural Alterations Associated with Stimulant Misuse Localized using Diffusion MRI Tractometry
Diffusion brain MRI (dMRI) studies of substance use disorders have reported widespread but modest white matter (WM) microstructural alterations with limited anatomical specificity. Here, we applied segment-wise along-tract 3D tractometry to brain dMRI scans to localize fine-scale WM alterations associated with stimulant misuse using two complementary analytical frameworks: Bundle Analytics (BUAN) and Medial Tractography Analysis (MeTA). We analyzed 3D profiles of widely-used diffusion metrics across 33 major WM bundles in independent cohorts of cocaine (74 cases;58 controls) and amphetamine (22 cases;18 controls) users, testing the statistical associations with brain microstructure of pooled stimulant effects, substance-specific effects, and direct comparisons between stimulant classes. Segment-wise analyses revealed focal differences localized to specific tract segments rather than uniform differences along entire bundles. In pooled stimulant misuse, convergent findings across analysis pipelines were localized to hippocampal pathways and were consistent with altered microstructural organization. Amphetamines misuse showed a broader pattern of segment-wise differences across commissural, projection, and association pathways, involving altered axonal organization. No robust segment-wise differences were detected for cocaine misuse or between stimulant classes. These results show that WM alterations are spatially localized and reproducible across tractometry frameworks, highlighting the value of along-tract 3D mapping for improving anatomical specificity in addiction neuroimaging.
- 14 November 2025
- Published by Springer Nature
- p. 210-220
FastEBM: Robust Disease Progression Inference at Scale
- 14 November 2025
- Published by Springer Nature
- p. 210-220
FastEBM: Robust Disease Progression Inference at Scale
- Open Access
Assessing the Influence of Tractography Methods on Detected White Matter Microstructure in Alzheimers disease
Tractometry enables detailed mapping of white matter microstructure along individual tracts and is widely used to study disease effects such as those seen in Alzheimer’s disease (AD). However, how different tractography algorithms influence tractometry outcomes remains unclear. Here, we compared whole-brain deterministic and probabilistic tractography using the BUndle ANalytics (BUAN) framework in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset, including 118 AD and 728 cognitively normal (CN) participants. Both approaches revealed the expected pattern of lower fractional anisotropy (FA) and higher mean, radial, and axial diffusivity (MD, RD, AxD) in AD, consistent with white matter degeneration. Despite broadly similar global trends, substantial bundle-level differences emerged between the two tractography methods. Probabilistic tracking produced stronger and more spatially extended effects in the fornix, a small and highly curved limbic pathway vulnerable to AD-related degeneration, whereas deterministic tracking showed greater sensitivity in the posterior segments of the right superior longitudinal fasciculus (SLF R). These discrepancies highlight that the choice of tractography algorithm can alter detecting disease effects, emphasizing the need for cross-method validation to ensure the robustness and interpretability of along-tract measures.
Open AccessAssessing the Influence of Tractography Methods on Detected White Matter Microstructure in Alzheimers disease
Tractometry enables detailed mapping of white matter microstructure along individual tracts and is widely used to study disease effects such as those seen in Alzheimer’s disease (AD). However, how different tractography algorithms influence tractometry outcomes remains unclear. Here, we compared whole-brain deterministic and probabilistic tractography using the BUndle ANalytics (BUAN) framework in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset, including 118 AD and 728 cognitively normal (CN) participants. Both approaches revealed the expected pattern of lower fractional anisotropy (FA) and higher mean, radial, and axial diffusivity (MD, RD, AxD) in AD, consistent with white matter degeneration. Despite broadly similar global trends, substantial bundle-level differences emerged between the two tractography methods. Probabilistic tracking produced stronger and more spatially extended effects in the fornix, a small and highly curved limbic pathway vulnerable to AD-related degeneration, whereas deterministic tracking showed greater sensitivity in the posterior segments of the right superior longitudinal fasciculus (SLF R). These discrepancies highlight that the choice of tractography algorithm can alter detecting disease effects, emphasizing the need for cross-method validation to ensure the robustness and interpretability of along-tract measures.
- Open Access
- 15 September 2025
- Published by Springer Nature in Research Square
Alzheimer’s Disease-Like Brain Pattern Biomarker: Capturing Risks and Predicting Disease Onset
Preventing Alzheimer’s disease (AD) requires early-warning biomarkers. We developed a Regional Vulnerability Index (RVI) that quantifies individual brain similarity to AD patients' expected brain deficit patterns. We calculated regional effect sizes to establish brain deficit patterns in amyloid-positive AD cases compared to amyloid-negative healthy controls. The RVI-AD was calculated as a linear index of individual similarity to this established brain pattern in AD. Initially, we demonstrated RVI-AD elevation associated with risk factors in 335 participants (mean age: 49±13 years) in the Amish Connectome Project, followed by an independent sample consisting of 26,010 participants (mean age: 64±7 years) from the UK Biobank. Genetic and cardiovascular risks were evaluated using APOE-e4 genotype and Framingham Cardiovascular Risk Scores (FCVRS), respectively. Additionally, we assessed the risk of converting from MCI to dementia in N=1,932 participants (mean age: ~74) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Participants with the APOE-e4 allele had significantly elevated RVI-AD indices (p<0.05); FCVRS significantly contributed to higher RVI-AD in an APOE-e4-specific manner (p<0.01), replicable across the samples. In the ADNI cohort, RVI-AD significantly predicted conversion from MCI to dementia in the next decade, particularly within the first 3 years (AUC=74%). In healthy individuals, the RVI-AD index detected the insidious impact of APOE-ε4 and cardiovascular risks in otherwise normally aging cohorts. Elevated RVI-AD also predicted conversion to dementia within 10 years in the older, high-risk cohort. Further development of this brain-pattern similarity-based approach may yield a noninvasive, clinically accessible biomarker to aid early detection of the subtle to more imminent effects of AD risks.
- 15 September 2025
- Published by Springer Nature in Research Square
Open AccessAlzheimer’s Disease-Like Brain Pattern Biomarker: Capturing Risks and Predicting Disease Onset
Preventing Alzheimer’s disease (AD) requires early-warning biomarkers. We developed a Regional Vulnerability Index (RVI) that quantifies individual brain similarity to AD patients' expected brain deficit patterns. We calculated regional effect sizes to establish brain deficit patterns in amyloid-positive AD cases compared to amyloid-negative healthy controls. The RVI-AD was calculated as a linear index of individual similarity to this established brain pattern in AD. Initially, we demonstrated RVI-AD elevation associated with risk factors in 335 participants (mean age: 49±13 years) in the Amish Connectome Project, followed by an independent sample consisting of 26,010 participants (mean age: 64±7 years) from the UK Biobank. Genetic and cardiovascular risks were evaluated using APOE-e4 genotype and Framingham Cardiovascular Risk Scores (FCVRS), respectively. Additionally, we assessed the risk of converting from MCI to dementia in N=1,932 participants (mean age: ~74) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Participants with the APOE-e4 allele had significantly elevated RVI-AD indices (p<0.05); FCVRS significantly contributed to higher RVI-AD in an APOE-e4-specific manner (p<0.01), replicable across the samples. In the ADNI cohort, RVI-AD significantly predicted conversion from MCI to dementia in the next decade, particularly within the first 3 years (AUC=74%). In healthy individuals, the RVI-AD index detected the insidious impact of APOE-ε4 and cardiovascular risks in otherwise normally aging cohorts. Elevated RVI-AD also predicted conversion to dementia within 10 years in the older, high-risk cohort. Further development of this brain-pattern similarity-based approach may yield a noninvasive, clinically accessible biomarker to aid early detection of the subtle to more imminent effects of AD risks.
- Open Access
Microstructural Mapping of Neural Pathways in Alzheimer's Disease using Macrostructure-Informed Normative Tractometry
Introduction Diffusion MRI is sensitive to the microstructural properties of brain tissues, and shows great promise in detecting the effects of degenerative diseases. However, many approaches analyze single measures averaged over regions of interest, without considering the underlying fiber geometry. Methods Here, we propose a novel Macrostructure-Informed Normative Tractometry (MINT) framework, to investigate how white matter microstructure and macrostructure are jointly altered in mild cognitive impairment (MCI) and dementia. We compare MINT-derived metrics with univariate metrics from diffusion tensor imaging (DTI), to examine how fiber geometry may impact interpretation of microstructure. Results In two multi-site cohorts from North America and India, we find consistent patterns of microstructural and macrostructural anomalies implicated in MCI and dementia; we also rank diffusion metrics’ sensitivity to dementia. Discussion We show that MINT, by jointly modeling tract shape and microstructure, has potential to disentangle and better interpret the effects of degenerative disease on the brain’s neural pathways.
Open AccessMicrostructural Mapping of Neural Pathways in Alzheimer's Disease using Macrostructure-Informed Normative Tractometry
Introduction Diffusion MRI is sensitive to the microstructural properties of brain tissues, and shows great promise in detecting the effects of degenerative diseases. However, many approaches analyze single measures averaged over regions of interest, without considering the underlying fiber geometry. Methods Here, we propose a novel Macrostructure-Informed Normative Tractometry (MINT) framework, to investigate how white matter microstructure and macrostructure are jointly altered in mild cognitive impairment (MCI) and dementia. We compare MINT-derived metrics with univariate metrics from diffusion tensor imaging (DTI), to examine how fiber geometry may impact interpretation of microstructure. Results In two multi-site cohorts from North America and India, we find consistent patterns of microstructural and macrostructural anomalies implicated in MCI and dementia; we also rank diffusion metrics’ sensitivity to dementia. Discussion We show that MINT, by jointly modeling tract shape and microstructure, has potential to disentangle and better interpret the effects of degenerative disease on the brain’s neural pathways.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S17)
Data harmonization across eight publicly available longitudinal studies of aging, neurodegeneration and dementia
Background: Large‐scale multi‐study analyses are required to ensure reproducibility, reliability and generalizability in mapping neurodegeneration and risk for ADRD. However, the heterogeneity in data collection paradigms can complicate and confound data pooling; data harmonization is essential. Longitudinal studies add to the complexity of harmonization as a variety of follow‐up time points and time encoding schemes are used. Here, we pool data from 8 publicly available longitudinal neuroimaging studies on neurodegeneration and dementia to highlight differences in: 1) diagnostic categorization of controls, and people with mild cognitive impairment, and dementia; 2) the extent of follow‐up visits across neuroimaging and clinical assessments; and 3) encodings of various meta‐data elements including scanner manufacturer, sex, and handedness. To allow a systematic approach to multi‐study dementia research, we propose an initial ontological framework for longitudinal data archival and retrieval, capable of capturing similar data elements within given themes while ensuring that unique differences across studies are retained.Method: AIBL, ADNI‐1, ADNI2/GO, ADNI‐3, OASIS‐2, OASIS‐3, PREVENT‐AD, and MIRIAD, were accessed. Study designs, inclusion and exclusion criteria, and downloaded data elements were used to describe diagnostic criteria, imaging data, demographic features, and longitudinal data collection schemes. We create common terms to map data elements across studies, and a consistent naming scheme for longitudinal data.Result: Figure 1 shows the breakdown of diagnostic labels per cohort, and highlights how different cognitive labels may be assigned to people with the same performance scores, for example, on the Mini Mental State Examination (MMSE). Figure 2 highlights the differences in longitudinal data collection schemes across cohorts, and in labels of commonly collected elements. Using common terms provided an easy way to simultaneously query data across all studies, while retaining a map back to the original terms. Figure 3 showcases our proposed naming scheme for capturing longitudinal data elements using a relational ontological framework. This framework successfully harmonized data across study demographics, timepoints, and imaging properties.Conclusion: Multi‐study data analyses are becoming common practice thanks to large scale efforts such as ENIGMA and GAAIN. Harmonization of meta‐data across studies will allow for efficient pooling of data for tracking disease progression and related risk over time.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S17)
Open AccessData harmonization across eight publicly available longitudinal studies of aging, neurodegeneration and dementia
Background: Large‐scale multi‐study analyses are required to ensure reproducibility, reliability and generalizability in mapping neurodegeneration and risk for ADRD. However, the heterogeneity in data collection paradigms can complicate and confound data pooling; data harmonization is essential. Longitudinal studies add to the complexity of harmonization as a variety of follow‐up time points and time encoding schemes are used. Here, we pool data from 8 publicly available longitudinal neuroimaging studies on neurodegeneration and dementia to highlight differences in: 1) diagnostic categorization of controls, and people with mild cognitive impairment, and dementia; 2) the extent of follow‐up visits across neuroimaging and clinical assessments; and 3) encodings of various meta‐data elements including scanner manufacturer, sex, and handedness. To allow a systematic approach to multi‐study dementia research, we propose an initial ontological framework for longitudinal data archival and retrieval, capable of capturing similar data elements within given themes while ensuring that unique differences across studies are retained.Method: AIBL, ADNI‐1, ADNI2/GO, ADNI‐3, OASIS‐2, OASIS‐3, PREVENT‐AD, and MIRIAD, were accessed. Study designs, inclusion and exclusion criteria, and downloaded data elements were used to describe diagnostic criteria, imaging data, demographic features, and longitudinal data collection schemes. We create common terms to map data elements across studies, and a consistent naming scheme for longitudinal data.Result: Figure 1 shows the breakdown of diagnostic labels per cohort, and highlights how different cognitive labels may be assigned to people with the same performance scores, for example, on the Mini Mental State Examination (MMSE). Figure 2 highlights the differences in longitudinal data collection schemes across cohorts, and in labels of commonly collected elements. Using common terms provided an easy way to simultaneously query data across all studies, while retaining a map back to the original terms. Figure 3 showcases our proposed naming scheme for capturing longitudinal data elements using a relational ontological framework. This framework successfully harmonized data across study demographics, timepoints, and imaging properties.Conclusion: Multi‐study data analyses are becoming common practice thanks to large scale efforts such as ENIGMA and GAAIN. Harmonization of meta‐data across studies will allow for efficient pooling of data for tracking disease progression and related risk over time.
- Open Access
- 13 December 2023
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (2) , 257-268
Cortical microstructural associations with CSF amyloid and pTau
Diffusion MRI (dMRI) can be used to probe microstructural properties of brain tissue and holds great promise as a means to non-invasively map Alzheimer’s disease (AD) pathology. Few studies have evaluated multi-shell dMRI models such as neurite orientation dispersion and density imaging (NODDI) and mean apparent propagator (MAP)-MRI in cortical gray matter where many of the earliest histopathological changes occur in AD. Here, we investigated the relationship between CSF pTau181 and Aβ1–42 burden and regional cortical NODDI and MAP-MRI indices in 46 cognitively unimpaired individuals, 18 with mild cognitive impairment, and two with dementia (mean age: 71.8 ± 6.2 years) from the Alzheimer’s Disease Neuroimaging Initiative. We compared findings to more conventional cortical thickness measures. Lower CSF Aβ1–42 and higher pTau181 were associated with cortical dMRI measures reflecting less hindered or restricted diffusion and greater diffusivity. Cortical dMRI measures, but not cortical thickness measures, were more widely associated with Aβ1–42 than pTau181 and better distinguished Aβ+ from Aβ- participants than pTau+ from pTau- participants. dMRI associations mediated the relationship between CSF markers and delayed logical memory performance, commonly impaired in early AD. dMRI metrics sensitive to early AD pathogenesis and microstructural damage may be better measures of subtle neurodegeneration in comparison to standard cortical thickness and help to elucidate mechanisms underlying cognitive decline.
- 13 December 2023
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (2) , 257-268
Open AccessCortical microstructural associations with CSF amyloid and pTau
Diffusion MRI (dMRI) can be used to probe microstructural properties of brain tissue and holds great promise as a means to non-invasively map Alzheimer’s disease (AD) pathology. Few studies have evaluated multi-shell dMRI models such as neurite orientation dispersion and density imaging (NODDI) and mean apparent propagator (MAP)-MRI in cortical gray matter where many of the earliest histopathological changes occur in AD. Here, we investigated the relationship between CSF pTau181 and Aβ1–42 burden and regional cortical NODDI and MAP-MRI indices in 46 cognitively unimpaired individuals, 18 with mild cognitive impairment, and two with dementia (mean age: 71.8 ± 6.2 years) from the Alzheimer’s Disease Neuroimaging Initiative. We compared findings to more conventional cortical thickness measures. Lower CSF Aβ1–42 and higher pTau181 were associated with cortical dMRI measures reflecting less hindered or restricted diffusion and greater diffusivity. Cortical dMRI measures, but not cortical thickness measures, were more widely associated with Aβ1–42 than pTau181 and better distinguished Aβ+ from Aβ- participants than pTau+ from pTau- participants. dMRI associations mediated the relationship between CSF markers and delayed logical memory performance, commonly impaired in early AD. dMRI metrics sensitive to early AD pathogenesis and microstructural damage may be better measures of subtle neurodegeneration in comparison to standard cortical thickness and help to elucidate mechanisms underlying cognitive decline.